D. Liénard

2.9k total citations
45 papers, 1.8k citations indexed

About

D. Liénard is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, D. Liénard has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 18 papers in Molecular Biology and 16 papers in Immunology. Recurrent topics in D. Liénard's work include Cutaneous Melanoma Detection and Management (20 papers), Immunotherapy and Immune Responses (14 papers) and Melanoma and MAPK Pathways (7 papers). D. Liénard is often cited by papers focused on Cutaneous Melanoma Detection and Management (20 papers), Immunotherapy and Immune Responses (14 papers) and Melanoma and MAPK Pathways (7 papers). D. Liénard collaborates with scholars based in Switzerland, Belgium and Netherlands. D. Liénard's co-authors include Ferdy J. Lejeune, Philippe Autier, Alexander M.M. Eggermont, Ulrich R. Kleeberg, A.M.M. Eggermont, Ferdinand Lejeune, Dirk Schadendorf, F. Lejeune, J. F. Doré and F. Rosenkaimer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

D. Liénard

45 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Liénard Switzerland 22 973 652 575 491 197 45 1.8k
Jerry Marsden United Kingdom 19 862 0.9× 251 0.4× 403 0.7× 524 1.1× 84 0.4× 32 1.6k
Georg Weinlich Austria 16 389 0.4× 582 0.9× 371 0.6× 186 0.4× 95 0.5× 27 1.4k
B. M. Czarnetzki Germany 16 319 0.3× 468 0.7× 360 0.6× 208 0.4× 52 0.3× 49 1.1k
Friedrich A. Bahmer Germany 20 592 0.6× 190 0.3× 189 0.3× 801 1.6× 24 0.1× 78 1.6k
Terufumi Kubo Japan 20 504 0.5× 437 0.7× 477 0.8× 129 0.3× 243 1.2× 92 1.3k
Claire Q. Wang United States 18 322 0.3× 834 1.3× 296 0.5× 1.1k 2.2× 54 0.3× 27 2.2k
A. Stratigos Greece 15 289 0.3× 279 0.4× 165 0.3× 478 1.0× 62 0.3× 23 1.0k
Phyllis F. Cheung Hong Kong 19 330 0.3× 571 0.9× 303 0.5× 303 0.6× 122 0.6× 36 1.5k
Teresa Fu United States 14 245 0.3× 164 0.3× 240 0.4× 340 0.7× 38 0.2× 19 894
Feng Fang United States 22 203 0.2× 319 0.5× 997 1.7× 196 0.4× 283 1.4× 40 1.8k

Countries citing papers authored by D. Liénard

Since Specialization
Citations

This map shows the geographic impact of D. Liénard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Liénard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Liénard more than expected).

Fields of papers citing papers by D. Liénard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Liénard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Liénard. The network helps show where D. Liénard may publish in the future.

Co-authorship network of co-authors of D. Liénard

This figure shows the co-authorship network connecting the top 25 collaborators of D. Liénard. A scholar is included among the top collaborators of D. Liénard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Liénard. D. Liénard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baurain, Jean‐François, Oliver Bechter, Carmen Orte Cano, et al.. (2022). Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients. SHILAP Revista de lepidopterología. 2. 1041819–1041819. 8 indexed citations
2.
Bouwhuis, Marna G., Stefan Suciu, François Salès, et al.. (2010). Prognostic value of serial blood S100B determinations in stage IIB–III melanoma patients: A corollary study to EORTC trial 18952. European Journal of Cancer. 47(3). 361–368. 34 indexed citations
3.
Kleeberg, Ulrich R., Stefan Suciu, E.‐B. Bröcker, et al.. (2003). Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. European Journal of Cancer. 40(3). 390–402. 145 indexed citations
4.
Martus, Peter, Cornelis J.A. Punt, Wim H.J. Kruit, et al.. (2002). Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments. European Journal of Cancer. 38(11). 1501–1511. 39 indexed citations
5.
Eggermont, Alexander M.M., Ulrich Keilholz, Philippe Autier, et al.. (2002). The EORTC Melanoma Group. European Journal of Cancer. 38. 114–119. 8 indexed citations
6.
Keilholz, Ulrich, C.J.A. Punt, M. Gore, et al.. (2000). Dacarbazine, cisplatin and IFN-alpha with or without IL-2 in advanced melanoma (EORTC trial 18951). Annals of Oncology. 11. 4. 15 indexed citations
7.
Liénard, D., Alexander M.M. Eggermont, Heimen Schraffordt Koops, et al.. (1999). Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastases. Melanoma Research. 9(5). 491–502. 112 indexed citations
8.
Autier, Philippe, J. F. Doré, Sylvie Négrier, et al.. (1999). Sunscreen Use and Duration of Sun Exposure: a Double-Blind, Randomized Trial. JNCI Journal of the National Cancer Institute. 91(15). 1304–1309. 177 indexed citations
9.
Leyvraz, Serge, Laurent A. Décosterd, Marina Bonfanti, et al.. (1999). Sequential administration of temozolomide and fotemustine: Depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours. Annals of Oncology. 10(7). 831–838. 40 indexed citations
10.
Keilholz, Ulrich, S.H. Goey, Cornelis J.A. Punt, et al.. (1997). Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.. Journal of Clinical Oncology. 15(7). 2579–2588. 139 indexed citations
11.
Autier, Philippe, et al.. (1997). Melanoma risk and residence in sunny areas. British Journal of Cancer. 76(11). 1521–1524. 51 indexed citations
12.
Cerottini, J C, D. Liénard, & Pedro Romero. (1996). Recognition of tumor-associated antigens by T-lymphocytes: Perspectives for peptide-based vaccines. Annals of Oncology. 7(4). 339–342. 2 indexed citations
13.
Klaase, Joost M., B.B.R. Kroon, Alexander Eggermont, et al.. (1995). A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities. European Journal of Cancer. 31(1). 58–63. 30 indexed citations
14.
Lejeune, Ferdy J., D. Liénard, Curzio Rüegg, & Serge Leyvraz. (1995). Soft tissue sarcoma therapy: prospects for future studies. European Journal of Surgical Oncology. 21(5). 474–477. 1 indexed citations
15.
Renard, Nathalie, D. Liénard, Laurence Lespagnard, et al.. (1994). Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα). International Journal of Cancer. 57(5). 656–663. 127 indexed citations
16.
Autier, Philippe, Ferdy J. Lejeune, D. Liénard, et al.. (1994). Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: An eortc multicenter case‐control study in Belgium, France and Germany. International Journal of Cancer. 58(6). 809–813. 117 indexed citations
17.
Lejeune, Ferdy J., D. Liénard, Serge Leyvraz, & René‐Olivier Mirimanoff. (1993). Regional therapy of melanoma. European Journal of Cancer. 29(4). 606–612. 63 indexed citations
18.
Swaak, A. J. G., D. Liénard, H. Schraffordt Koops, Ferdy J. Lejeune, & A.M.M. Eggermont. (1993). Effects of recombinant tumour necrosis factor (rTNF‐α) in cancer. Observations on the acute phase protein reaction and immunoglobulin synthesis after high dose recombinant TNF‐α administration in isolated limb perfusions in cancer patients. European Journal of Clinical Investigation. 23(12). 812–818. 26 indexed citations
19.
Liénard, D., et al.. (1993). Local Administration of α‐MSH Exerts a Trophic Effect on the 200‐kDa Neurofilament in Sciatic Rat Nerve. Annals of the New York Academy of Sciences. 680(1). 655–659. 1 indexed citations
20.
Autier, Philippe, M. Joarlette, F. Lejeune, et al.. (1991). Cutaneous malignant melanoma and exposure to sunlamps and sunbeds. Melanoma Research. 1(1). 69–69. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerry Marsden Breakdown of academic impact, for papers by Georg Weinlich Breakdown of academic impact, for papers by B. M. Czarnetzki Breakdown of academic impact, for papers by Friedrich A. Bahmer Breakdown of academic impact, for papers by Terufumi Kubo Breakdown of academic impact, for papers by Claire Q. Wang Breakdown of academic impact, for papers by A. Stratigos Breakdown of academic impact, for papers by Phyllis F. Cheung Breakdown of academic impact, for papers by Teresa Fu Breakdown of academic impact, for papers by Feng Fang
Rankless by CCL
2026